Precision breast cancer trial shows improved treatment by tumor subtype

byUniversity of California, San FranciscoEfficacy of Dato-DXd + durvalumab treatment. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-03267-1Despite recent advances in the trea

Updated on: October 21,2024 0

Precision breast cancer trial shows improved treatment by tumor subtype

byUniversity of California, San FranciscoEfficacy of Dato-DXd + durvalumab treatment. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-03267-1Despite recent advances in the trea

Updated on:October 21,2024 0

Clinical trial finds new drug significantly extends lives of breast cancer patients

byLudwig Maximilian University of MunichKaplan–Meier analysis of key efficacy endpoints in patients with baseline BMs. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-03261-7Pa

Updated on: October 21,2024 0

Clinical trial finds new drug significantly extends lives of breast cancer patients

byLudwig Maximilian University of MunichKaplan–Meier analysis of key efficacy endpoints in patients with baseline BMs. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-03261-7Pa

Updated on:October 21,2024 0

New book explores the history of the phony cancer drug Krebiozen

by Sharita Forrest,University of Illinois at Urbana-ChampaignCredit: 3 Fields BooksIn March 1951, Andrew Ivy—at the time, one of the most renowned scientists and medical ethicists in the U.S.—he

Updated on: October 21,2024 0

New book explores the history of the phony cancer drug Krebiozen

by Sharita Forrest,University of Illinois at Urbana-ChampaignCredit: 3 Fields BooksIn March 1951, Andrew Ivy—at the time, one of the most renowned scientists and medical ethicists in the U.S.—he

Updated on:October 21,2024 0

Trial supports radiotherapy and cisplatin remaining as the standard of care for p16+ oropharyngeal cancer

by NRG OncologyCredit: Pixabay/CC0 Public DomainThe NRG Oncology NRG-HN005 phase II/III clinical trial has not met the non-inferiority criteria to proceed to the phase III portion of the study. The ph

Updated on: October 21,2024 0

Trial supports radiotherapy and cisplatin remaining as the standard of care for p16+ oropharyngeal cancer

by NRG OncologyCredit: Pixabay/CC0 Public DomainThe NRG Oncology NRG-HN005 phase II/III clinical trial has not met the non-inferiority criteria to proceed to the phase III portion of the study. The ph

Updated on:October 21,2024 0

Clinical trial: Addition of atezolizumab to standard care does not improve limited-stage small cell lung cancer survival

by NRG OncologyCredit: Unsplash/CC0 Public DomainThe addition of the cancer immunotherapy drug atezolizumab to the standard of care concurrent chemoradiation (cCRT) did not improve overall survival fo

Updated on: October 21,2024 0

Clinical trial: Addition of atezolizumab to standard care does not improve limited-stage small cell lung cancer survival

by NRG OncologyCredit: Unsplash/CC0 Public DomainThe addition of the cancer immunotherapy drug atezolizumab to the standard of care concurrent chemoradiation (cCRT) did not improve overall survival fo

Updated on:October 21,2024 0

2023 cisplatin shortage tied to use of alternatives for head, neck cancer

by Lori SolomonThe 2023 cisplatin shortage led to a shift in utilization to alternative therapies for head and neck cancer (HNC), resulting in significant cost increases, according to a study presente

Updated on: October 18,2024 0

2023 cisplatin shortage tied to use of alternatives for head, neck cancer

by Lori SolomonThe 2023 cisplatin shortage led to a shift in utilization to alternative therapies for head and neck cancer (HNC), resulting in significant cost increases, according to a study presente

Updated on:October 18,2024 0

Gut bacteria engineered to act as tumor GPS for immunotherapies

byDana-Farber Cancer InstituteBacteria displaying hDR18 enhance anti-tumor responses of MSLN-CAR NK cells. Credit:Nature Biotechnology(2024). DOI: 10.1038/s41587-024-02418-6Immunothe

Updated on: October 10,2024 0

Gut bacteria engineered to act as tumor GPS for immunotherapies

byDana-Farber Cancer InstituteBacteria displaying hDR18 enhance anti-tumor responses of MSLN-CAR NK cells. Credit:Nature Biotechnology(2024). DOI: 10.1038/s41587-024-02418-6Immunothe

Updated on:October 10,2024 0

Critical Review of the Role of Exosomal miR-519a-3p in Gastric Cancer Liver Metastasis through M2 Macrophage Polarization

Updated on: October 04,2024 0

Critical Review of the Role of Exosomal miR-519a-3p in Gastric Cancer Liver Metastasis through M2 Macrophage Polarization

Updated on:October 04,2024 0

Interpreting and Commenting on the Role of Oct4 in M2 Macrophage Polarization and Tumor Progression in Lung Cancer

Updated on: October 01,2024 0

Interpreting and Commenting on the Role of Oct4 in M2 Macrophage Polarization and Tumor Progression in Lung Cancer

Updated on:October 01,2024 0

Researchers compare tumor characteristics, survival outcome of different bile duct cancers

byBoston University School of MedicineCredit: CC0 Public DomainCholangiocarcinoma (CCA) or bile duct cancer, is a rare, aggressive liver cancer with a poor prognosis, which occurs mostly in peop

Updated on: September 30,2024 0

Researchers compare tumor characteristics, survival outcome of different bile duct cancers

byBoston University School of MedicineCredit: CC0 Public DomainCholangiocarcinoma (CCA) or bile duct cancer, is a rare, aggressive liver cancer with a poor prognosis, which occurs mostly in peop

Updated on:September 30,2024 0

New precision tools make quick work of tumor dissection

by Andrew Myers,Stanford UniversityScanning microscopy images of the microDicer (blade spacings 200 μm, 400 μm, and 800 μm, respectively) and microGrater. Credit: Seth Cordts and Saisneha Koppak

Updated on: September 30,2024 0

New precision tools make quick work of tumor dissection

by Andrew Myers,Stanford UniversityScanning microscopy images of the microDicer (blade spacings 200 μm, 400 μm, and 800 μm, respectively) and microGrater. Credit: Seth Cordts and Saisneha Koppak

Updated on:September 30,2024 0

New, rare type of small cell lung cancer identified

by Ian Demsky,Memorial Sloan Kettering Cancer CenterOn the left, four pathology images from a patient with atypical small cell lung cancer show hallmarks of carcinoid cancer in the lungs (thorax

Updated on: September 30,2024 0

New, rare type of small cell lung cancer identified

by Ian Demsky,Memorial Sloan Kettering Cancer CenterOn the left, four pathology images from a patient with atypical small cell lung cancer show hallmarks of carcinoid cancer in the lungs (thorax

Updated on:September 30,2024 0